YY/T 1453-2016Tissue engineering medical device products--Methods for determination of type I collagen (English PDF)
组织工程医疗器械产品 I型胶原蛋白表征方法
This is a limited preview
Buy now to download the full PDF (16 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1453-2016 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
July 29, 2016
Implementation date
June 1, 2017
Scope
YY/T 1453-2016 is the English-translated version of 组织工程医疗器械产品 I型胶原蛋白表征方法.
YY/T 1453-2016 is the Chinese pharmaceutical industry standard that gives the test methods for characterizing type I collagen prepared for tissue engineering medical device products, whether extracted, separated and purified from tissue such as skin, tendon or bone, or obtained from other sources.
Its normative appendices set out how to determine the purity of the collagen, the hydroxyproline content, the melting point, trace elements and the total sugar content, drawing on the Pharmacopoeia of the People's Republic of China and on GB/T food analysis methods for arsenic, mercury and fats.
It also defines type I collagen and the adventitious agents - bacteria, fungi, mycoplasma and viruses - that may be introduced during production, and refers biological evaluation to GB/T 16886.1. Issued on 29 July 2016, it has applied since 1 June 2017.
Found what you need?
Document preview — YY/T 1453-2016
National Standard of the People's Republic of China
- ICS
- 11.040.40
- Classification
- C 35
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Preface
- 1 Scope
- 2 normative reference document
- 3 Terms and definitions
- Appendix A (normative) Determination of purity of type I collagen
- Appendix B (normative) Determination of hydroxyproline content
- Appendix C (normative) Melting point determination
- Appendix D (normative) Trace element analysis
- Appendix E (normative appendix) Determination of total sugar content
Foreword
This standard is drafted in accordance with the rules given in GB/T 1.1-2009.
1 Scope
This standard specifies the test methods for the preparation of type I collagen for tissue engineering medical device products. This type of prescription is prescribed by this standard Collagen includes I derived from tissue, such as skin, tendons, bones, etc., extracted, isolated and purified, or other sources Type collagen.
2 Normative reference documents
The following documents are indispensable for the application of this document. For dated references, only the dated edition applies to this document. For undated references, the latest edition (including all modifications) applies to this document.
Food safety - Determination of total arsenic and inorganic arsenic in national standard foodstuffs GB 5009.11-2014 Food safety - Determination of total mercury and organic mercury in national foodstuffs GB 5009.17-2014
GB/T 16886.1 Biological evaluation of medical devices - Part 1. Evaluation and testing in risk management (ISO 10993-1, IDT)
GB/T 22223-2008 Determination of total fat, saturated fats (acids), unsaturated fats (acids) in food - Hydrolysis - Gas phase color Spectrum method Pharmacopoeia of the People's Republic of China (2015)
3 Terms and definitions
The following terms and definitions apply to this document.
3.1 Type I collagen type Icolagen
The most abundant collagen protein, which is expressed in the mammalian tissue by the COL1A1 gene encoding the alpha chain and the COL1A2 gene, In fibrous collagen.
Note 1. The peptide chain of type I collagen consists of repeating glycine-XY (proline often occupies X-position, hydroxyproline occupies Y position) amino acid sequence.
Type I collagen is rich in glycine (Gly), L-alanine (L-Ala), L-proline (L-Pro) and 4-hydroxyproline (4-Hypro)
And does not contain L-tryptophan (L-Try).
Note 2. Collagen has three alpha chains formed by three helices. In the case of heating (eg, above 60 ° C) the collagen alpha chain triple helix structure is irreversible Denatured into a single alpha chain and some beta and gamma bands (ie gelatin).
Note 3. often associated with type I collagen type III collagen and V collagen, in addition to non-collagen-like proteins such as elastin and other structural molecules (amino Polysaccharides, lipoproteins and glycoprotein complexes).
3.2 Exogenous factor adventitiousagents
Contaminants present in type I collagen, including bacteria, fungi, mycoplasma and exogenous viruses. These substances may be inadvertently The ground is introduced into the production process and the final product.
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 16 pages — is available in the English PDF.
Referenced standards
Normative references
- GB 5009.11-2014National food safety standard - Determination of total arsenic and inorganic arsenic in food
- GB 5009.17-2014Determination of total mercury and organic-mercury in foods
- GB/T 16886.1Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
GB/T 22223-2008
Cited by
- YY/T 1805.3-2022Tissue engineering medical device products—Collagen protein - Part 3: Quantification of collagen based on marker peptide detection—Liquid chromatography-mass spectrometry
- YY/T 1849-2022Recombinant collagen protein
- YY/T 1805.2-2021Tissue engineering medical device products—Collagen protein - Part 2: Determination of molecular weight of type I collagen—Sodium dodecyl sulfate polyacrylamide gel electrophoresis
Similar standards
How to Download YY/T 1453-2016
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 16886.1-2022 — Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
YY/T 0297-2026 — General requirements for clinical investigation of medical devices
YY/T 0479-2026 — Medical diagnostic X-ray tube assemblies and X-ray source assemblies - Determination of maximum symmetric radiation field
Secure payment via Stripe
Payments accepted
YY/T 1453-2016
$285.00